Jennifer Susanne Carter, MSN, NP-C

84% fewer Medicare Part D claims than the average family nurse practitioner in 2024

209 Medicare Part D claims for 78 beneficiaries, against an average of 1,305 among the 140,557 providers of this specialty who prescribed in Part D. Brand-name drugs were 47% of claims. 19 claims were for opioids.

Most prescribed

1. Ibrance63 claims
2. Lorazepam27 claims
3. Verzenio17 claims
4. Anastrozole16 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 77.3 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $6,959.02

25 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 99,489 providers of this specialty with any payment received $650.95 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.